Reduced antigenicity of naturally occurring Hepatitis B surface antigen variants with substitutions the amino acid residue 126

Intervirology

Volumn 51, Issue 6, 2009, Pages 400-406

  Qiu, Song ^a   Zhang, Jiming ^c   Tian, Yongjun ^b   Yang, Yinke ^a   Huang, Hanju ^a   Yang, Dongliang ^b   Lu, Mengji ^a,d   Xu, Yang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Amino acid residue 126; Hepatitis B surface antigen; Hepatitis B virus

Indexed keywords

ALANINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LEUCINE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SERINE; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; CASE REPORT; CHEMOLUMINESCENCE; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; MOLECULAR CLONING; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS INFECTION; VIRUS ISOLATION;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; CELL CULTURE TECHNIQUES; DNA, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MOLECULAR SEQUENCE DATA;

HEPATITIS B VIRUS;

EID: 61349150568     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000205265     Document Type: Article

References (44)

1. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1981; 1: 377-385.
2. Kay A, Zoulim F: Hepatitis B virus genetic variability and evolution. Virus Res 2007; 127: 164-176.
3. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M: Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987; 61: 3030-3034.
4. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO: Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309.
5. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-329.
6. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman WF, Thomas HC: Loss of the common 'A' determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 1992; 90: 2543-2547.
7. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR: A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 1994; 75: 443- 448.
8. Wallace LA, Echevarria JE, Echevarria JM, Carman WF: Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 1994; 170: 1300- 1303.
9. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M: Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 2671-2676.
10. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC: A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 1995; 21: 273-278.
11. Ni F, Fang D, Gan R, Li Z, Duan S, Xu Z: A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. Res Virol 1995; 146: 397-407.
12. Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, Waters J, Kliem V, Muller R, Thomas HC, Manns MP: Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489-493.
13. Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y: Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996; 77: 1825-1831.
14. Carman WF: The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4(suppl 1):11-20.
15. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R: The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997; 26: 1658-1666.
16. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH: Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 1997; 176: 427-430.
17. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS: Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27: 213-222.
18. Grethe S, Monazahian M, Bohme I, Thomssen R: Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998; 72: 7692-7696.
19. He JW, Lu Q, Zhu QR, Duan SC, Wen YM: Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization. Vaccine 1998; 16: 170-173.
20. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G: Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998; 27: 254-263.
21. Carman WF, Owsianka A, Wallace LA, Dow BC, Mutimer DJ: Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol 1999; 31: 195-201.
22. Gunther S, Fischer L, Pult I, Sterneck M, Will H: Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999; 52: 25-137.
23. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL: Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312-1317.
24. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P: Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60: 113-121.
25. Weinberger KM, Bauer T, Bohm S, Jilg W: High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-1174.
26. Cooreman MP, Leroux-Roels G, Paulij WP: Vaccine- and hepatitis B immune globulininduced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001; 8: 237- 247.
27. Hino K, Katoh Y, Vardas E, Sim J, Okita K, Carman WF: The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine 2001; 19: 3912-3918.
28. Lu M, Lorentz T: De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Infect Dis 2003; 187: 1323-1326.
29. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS: Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol 1997; 78: 2639-2645.
30. Cooreman MP, van Rossmalen MH, te Morsche R, Sunnen CM, de Ven EM, Jansen JB, Tytgat GN, de Wit PL, Paulij WP: Characterization of the reactivity pattern of murine monoclonal antibodies against wildtype hepatitis B surface antigen to G145R and other naturally occurring 'a' loop escape mutations. Hepatology 1999; 30: 1287-1292.
31. Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M: Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 2004; 329: 454-464.
32. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D: The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 2007; 45: 2971-2978.
33. Ohnuma H, Machida A, Okamoto H, Tsuda F, Sakamoto M, Tanaka T, Miyakawa Y, Mayumi M: Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r. J Virol 1993; 67: 927- 932.
34. Ren F, Tsubota A, Hirokawa T, Kumada H, Yang Z, Tanaka H: A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene 2006; 383: 43-51.
35. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M: Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 2671-2676.
36. Zhang YY, Nordenfelt E, Hansson BG: Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand J Infect Dis 1996; 28: 9-15.
37. Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y: Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996; 77: 1825-1831.
38. Mesenas SJ, Chow WC, Zhao Y, Lim GK, Oon CJ, Ng HS: Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol 2002; 17: 148-152.
39. Wang YM, Ng WC, Lo SK: Detection of pre- S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol 1999; 34: 600-606.
40. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL: Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312-1317.
41. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S: Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32: 264-268.
42. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M: Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 2007; 44: 1161- 1169.
43. Antoni BA, Rodriguez-Crespo I, Gomez- Gutierrez J, Nieto M, Peterson D, Gavilanes F: Site-directed mutagenesis of cysteine residues of hepatitis B surface antigen. Analysis of two single mutants and the double mutant. Eur J Biochem 1994; 222: 121-127.
44. Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang DL, Jilg W, Roggendorf M, Lu M: Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 2004; 329: 454-464.